SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class A

Alphabet Inc Class A

GOOGL is trending as investors assess its potential to lead in AI, especially following positive reviews of its Gemini 3 model and Nano Banana Pro. Community discussion highlights a possible rotation from NVDA to GOOGL, with some analysts suggesting that Google's custom silicon gives it a cost advantage. Despite broader market concerns about an AI bubble, GOOGL's diverse business and strong balance sheet are seen as positives.

Alphabet Inc - Ordinary Shares - Class C

Alphabet (GOOG) is trending as community members crown it an AI race winner after news of Meta potentially using Google's TPUs. Bullish sentiment is fueled by strong analyst ratings and the release of Gemini 3, with some investors anticipating further gains and new all-time highs. Discussions also involve GOOG's dominance and potential impact on competitors like NVDA and MSFT.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is trending due to concerns about increasing competition, particularly following news that Meta is considering using Google's TPUs in their data centers, potentially impacting NVIDIA's market share. The community is debating the long-term implications of this shift and whether NVIDIA's dominance in the AI chip market is threatened. Some believe this is an overblown reaction and a buying opportunity, while others fear a significant correction.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom is trending amid optimism in the AI sector, particularly due to its partnership with Google on Tensor Processing Units (TPUs) for the Gemini 3 model, potentially challenging Nvidia's dominance. The community is discussing Broadcom's potential to reach new price levels, with some analysts setting new price targets, and highlighting its solid fundamentals and attractive growth prospects in the AI infrastructure space. Investors are also weighing in on potential delays of semiconductor tariffs and impacts from broader market trends.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

SanDisk is trending as the stock price increases rapidly, fueled by optimism around memory demand and AI data centers; some investors are discussing if a buyout is inevitable. The community is debating whether the stock is overvalued, while others point to strong fundamentals and a potential S&P 500 addition. Discussions include short squeeze potential and extreme volatility.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta is gaining attention as a high-throughput, compliance-focused blockchain designed for institutional use, with discussions highlighting its potential to underpin real-world asset tokenization and regulated financial flows, contrasting it with other crypto ecosystems like NEAR, BNB, and Aptos; The community is actively debating its competitive advantages, especially around settlement speed, scalability, and regulatory alignment; backed by Eric Schmidt.

Nukkleus, Inc. is a financial technology company, which engages in the provision of blockchain-enabled technology solutions. It also offers software and technology solutions for worldwide crypto and foreign exchange transactions with a focus on the movement of funds via crypto rails and back-to-back access to fiat conversion in a compliant regulated fashion. It operates through the following geographical segments: United States, United Kingdom, and Malta. The company was founded on May 24, 2019 and is headquartered in New York, NY.

Nukkleus Inc - Ordinary Shares - New

Nukkleus Inc

Nukkleus Inc is trending as investors discuss its potential short squeeze and upcoming shareholder vote regarding the acquisition of Star 26 Capital. Community members are speculating on the impact of the acquisition on Nukkleus' position in the defense sector, particularly regarding Iron Dome technology. Some traders are closely monitoring volume and price action, anticipating a significant move following the news.

The Stellar network is an open source, distributed, and community owned network used to facilitate cross-asset transfers of value. Stellar aims to help facilitate cross-asset transfer of value at a fraction of a penny while aiming to be an open financial system that gives people of all income levels access to low-cost financial services. Stellar can handle exchanges between fiat-based currencies and between cryptocurrencies. Stellar.org, the organization that supports Stellar, is centralized like XRP and meant to handle cross platform transactions and micro transactions like XRP. However, unlike Ripple, Stellar.org is non-profit and their platform itself is open source and decentralized.   Stellar was founded by Jed McCaleb in 2014. Jed McCaleb is also the founder of Mt. Gox and co-founder of Ripple, launched the network system Stellar with former lawyer Joyce Kim. Stellar is also a payment technology that aims to connect financial institutions and drastically reduce the cost and time required for cross-border transfers. In fact, both payment networks used the same protocol initially.  Distributed Exchange Through the use of its intermediary currency Lumens (XLM), a user can send any currency that they own to anyone else in a different currency.  For instance, if Joe wanted to send USD to Mary using her EUR, an offer is submitted to the distributed exchange selling USD for EUR. This submitted offer forms is known as an order book. The network will use the order book to find the best exchange rate for the transaction in-order to minimize the fee paid by a user.  This multi-currency transaction is possible because of "Anchors". Anchors are trusted entities that hold people’s deposits and can issue credit. In essence, Anchors serves as the bridge between different currencies and the Stellar network.  Lumens (XLM) Lumens are the native asset (digital currency) that exist on the Stellar network that helps to facilitate multi-currency transactions and prevent spams. For multi-currency transactions, XLM is the digital intermediary that allows for such a transaction to occur at a low cost.  In-order to prevent DoS attacks (aka spams) that would inevitably occur on the Stellar network, a small fee of 0.00001 XLM is associated with every transaction that occurs on the network. This fee is small enough so it does not significantly affect the cost of transaction, but large enough so it dissuades bad actors from spamming the network.   Prior to Protocol 12, Stellar had a built-in inflation mechanism conceived to allow account holders to collectively direct inflation-generated lumens toward projects built on Stellar.  As the network evolved and grew, it became increasingly clear that inflation wasn’t working as intended — account holders either didn’t set their inflation destination or joined inflation pools to claim the inflation themselves, and the operational costs associated with inflation payments continued to rise — and so a protocol change to disable inflation was proposed, implemented, voted on by validators, and ultimately adopted as part of a network upgrade.  The inflation operation is now deprecated. https://developers.stellar.org/docs/glossary/inflation/

Stellar Lumens

Stellar Lumens is trending as traders discuss its potential and recent price action, with some anticipating a move towards higher price targets. Community members are weighing in on XLM's utility, especially in cross-border payments, and comparing it to other cryptocurrencies. Some traders are also discussing potential entry points and expressing both bullish and bearish sentiments.

Zoom Communications, Inc. engages in the provision of a communications and collaboration platform. It operates through the following geographical segments: Americas, Asia Pacific, and Europe, Middle East, and Africa. The company was founded by Eric S. Yuan in 2011 and is headquartered in San Jose, CA.

Zoom Communications Inc. - Ordinary Shares - Class A

Zoom Video Communications, Inc.

Zoom is trending, with community members highlighting its large cash reserves and share buybacks, while others express concerns about competition and limited growth prospects. Some traders are discussing potential shorting opportunities, while others see a long-term buying opportunity due to the company's AI potential and strong balance sheet. Overall, the conversation is centered around whether Zoom can reignite growth in a competitive market and if its current valuation is justified.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad ($MON) is trending as the newly released crypto aims to capitalize on the current booming market. Community members are actively discussing potential entry points and expressing optimism, comparing its potential to established players like Solana and Ethereum. The recent addition of a chart feature and a temporary chat reset have also sparked discussion.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>UBS said that it believes Micron's cycle will be more durable this time as high-bandwidth memory "crowds out" the traditional memory market.</li><li>The firm added that most, if not all, of the industry's capacity additions through 2027 will likely be directed toward high-bandwidth memory.</li><li>Retail sentiment on Micron remained unchanged in the ‘bullish’ territory, with message volumes at ‘high’ levels, according to data from Stocktwits.</li></ul>Micron Technology (MU) became the top trending ticker on Stocktwits after UBS raised its price target on the stock to $275 from $245 and noted that the company is likely tracking above the high end of its guidance.UBS maintained a ‘Buy’ rating on the shares, according to TheFly. The firm said that its recent channel checks indicate "tight" supply conditions persist. Shares of Micron were down nearly 9% in early trading on Thursday.Despite the lack of a positive preannouncement, Micron is likely tracking above the high end of its guidance with double data rate five contract negotiations now edging toward up 20% quarter-over-quarter or higher, UBS noted.UBS said that it believes Micron's cycle will be more durable this time as high-bandwidth memory "crowds out" the traditional memory market. Most, if not all, of the industry's capacity additions through 2027 will likely go to high-bandwidth memory, the firm added.<h2 class="st-heading-2">Semiconductor Tariffs</h2>On Wednesday, according to a Reuters report, U.S. officials are privately saying that they might not levy the long-promised semiconductor tariffs soon. The report, citing people with knowledge of the matter, noted that officials relayed these messages over the last several days to stakeholders in the government and private industry.The report added that the Trump administration is trying not to provoke China and is taking a cautious stance. The news comes as a heave of relief for several companies in the space, including AMD (AMD), Intel (INTC), Marvell (MRVL), Micron (MU) and Nvidia (NVDA), among others.<h2 class="st-heading-2">What Is Retail Thinking?</h2>Retail sentiment around Micron remained unchanged in the ‘bullish’ territory, with message volumes at ‘high’ levels, according to data from Stocktwits.A user on Stocktwits noted that Micron has signed contracts for years with significant growth and revenue, adding that UBS’ $275 price target “is very conservative.”<stembedurl>https://stocktwits.com/84Hawk/message/636918185</stembedurl><a href="https://stocktwits.com/symbol/MU">Shares of Micron</a> have gained over 150% this year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/bbwi-stock-cracks-premarket-ceo-warns-of-softer-q3/cLPAKD6REa5">BBWI Stock Cracks After CEO Warns Of Tough Holiday Quarter, Slashes Full-Year Guidance</a>

 The logo for Micron Technology is posted at their headquarters on June 25, 2025 in San Jose, California. 

Micron Stock Draws Investor Attention Following A Price Target Boost From UBS 

UBS maintained a ‘Buy’ rating on the shares and noted that its recent channel checks indicate "tight" supply conditions persist.

Equity

<ul class="summary-bullets"><li>The company said that the late-stage study of Mitapivat in patients with sickle cell disease met the primary endpoint of hemoglobin response.&nbsp;</li><li>The drug also yielded positive outcomes on change from baseline in hemoglobin concentration and indirect bilirubin levels compared with placebo.&nbsp;</li><li>While Mitapivat also showed a reduction in the primary endpoint of annualized rate of sickle cell pain crises compared to placebo, this trend did not achieve statistical significance, the company noted.</li></ul>Shares of Agios Pharmaceuticals, Inc. (AGIO) slumped 48% on Wednesday after the company reported mixed results from its drug trial in sickle cell disease.Sickle cell disease is an inherited blood disorder where red blood cells become rigid, sickle-shaped, and unable to flow easily through blood vessels, causing pain and organ damage. The condition leads to complications like painful episodes or crises, anemia, infections, stroke, and damage to organs.<h2 class="st-heading-2">What Did The Study Show?</h2>The company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/11/19/3190791/31990/en/Agios-Announces-Topline-Results-from-RISE-UP-Phase-3-Trial-of-Mitapivat-in-Sickle-Cell-Disease.html">said</a> that the late-stage study of Mitapivat in patients aged 16 years and older with sickle cell disease met the primary endpoint of hemoglobin response, with the drug demonstrating a statistically significant improvement compared to placebo. Hemoglobin response is defined as an increase from baseline in average hemoglobin by more than or equal to 1.0 g/dL.The drug also showed positive effects on changes from baseline in hemoglobin concentration and indirect bilirubin levels compared with placebo.While Mitapivat also showed a reduction in the primary endpoint of annualized rate of sickle cell pain crises (SCPCs) or acute pain needing medical contact compared to placebo, this trend did not achieve statistical significance, the company noted. Further, there were no improvements from baseline on fatigue scores among patients, the company noted.The firm now expects to share the comprehensive results from the clinical program with the FDA in the first quarter of 2026 and seek potential U.S. regulatory approval.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/AGIO">AGIO stock</a> jumped from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume increased from ‘high’ to ‘extremely high’ levels.AGIO stock is down by 28% this year and by 57% over the past 12 months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/kzia-stock-soars-after-company-stage-iv-cancer-patients-shows-initial-complete-remission-on-its-drug-combination/cLPoQdMREBN">KZIA Stock Soars After Stage IV Cancer Patient Shows Initial Complete Remission On Its Drug Combination</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, the Agios Pharmaceuticals logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

AGIO Stock Cracks After Sickle-Cell Disease Drug Delivers Mixed Results In Late-Stage Trial 

 Sickle cell disease is an inherited blood disorder where red blood cells become rigid, sickle-shaped, and unable to flow easily through blood vessels, causing pain and organ damage.

<ul class="summary-bullets"><li>Olema’s lead product candidate, Palazestrant, belongs to the same class of drugs as Roche’s and is being studied in breast cancer.&nbsp;</li><li>Oppenheimer raised its price target on Olema Oncology to $45 from $22 and kept an ‘Outperform’ rating on the shares.&nbsp;</li><li>The analyst’s new price target implies about a 428% upside from the stock’s Monday closing price.</li></ul>Shares of Olema Pharmaceuticals Inc. (OLMA) more than doubled Tuesday morning on the heels of Roche announcing positive results from its late-stage trial in breast cancer.Roche was <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.roche.com/media/releases/med-cor-2025-11-18">evaluating</a> Giredestrant as an adjuvant endocrine treatment for people with certain types of early-stage breast cancer. In the study, Giredestrant treatment showed a statistically significant and clinically meaningful improvement in invasive disease-free survival compared with standard-of-care endocrine therapy.Giredestrant is an investigational, oral, selective oestrogen receptor degrader or SERD. According to Roche, this is the first late-stage study of a SERD to demonstrate a significant benefit in the adjuvant setting.<h2 class="st-heading-2">Expert Take</h2>As per Oppenheimer, Olema shares were trading pre-market on news that Roche's (RHHBY) trial met its primary endpoint. The analyst subsequently raised its price target on Olema Oncology to $45 from $22 and kept an ‘Outperform’ rating on the shares.The analyst’s new price target implies about a 428% upside from the stock’s Monday closing price.Oppenheimer said it was not expecting this readout, as the entire narrative has been around Roche's different breast cancer clinical trials. Nonetheless, the data are a welcome surprise, it added.Early breast cancer is a multi-billion-dollar market, and one that the firm did not have in its model. These data also incrementally derisk another Roche drug trial, which is testing oral SERDS against aromatase inhibitors in the frontline metastatic setting, Oppenheimer added.Olema’s lead product candidate, Palazestrant, is also a SERD being investigated in patients with recurrent, locally advanced, or metastatic forms of breast cancer. It is being evaluated as a single agent in a late-stage trial and in combination with ribociclib in another late-stage trial.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/OLMA">OLMA stock</a> jumped from ‘bearish’ to ‘extremely bullish’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:622/59;" src="data:image/png;base64,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" width="622" height="59" alt="OLMA's Sentiment Meter and Message Volume as of 9:46 a.m. ET on Nov. 18, 2025 | Source: Stocktwits"><figcaption>OLMA's Sentiment Meter and Message Volume as of 9:46 a.m. ET on Nov. 18, 2025 | Source: Stocktwits</figcaption></figure> A Stocktwits user expressed pessimism about the stock, noting that the hype had passed by pre-market hours, when the stock was up over 200%.<stembedurl>https://stocktwits.com/ChannelRed/message/636586904</stembedurl>Another user, however, believes the stock will touch $100.<stembedurl>https://stocktwits.com/murphylaw/message/636586451</stembedurl>OLMA stock is up by 233% this year and by 125% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/zymeworks-shifts-to-royalty-driven-model-approves-125-m-buyback-plan/cLPVdKtRE7F">Zymeworks Shifts To Royalty-Driven Model From Licensed Drugs, Approves $125M Buyback Plan</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Rising stock market chart on a trading board background.

OLMA Stock Doubles After Roche Cancer Drug Trial Yields Positive Results

Roche was evaluating Giredestrant as an adjuvant endocrine treatment for people with certain types of early-stage breast cancer.

In this photo illustration, the Scholar Rock Holding logo is seen displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Why Did Scholar Rock Soar 26% Today?

The company is planning to reapply for approval of a muscle atrophy therapy in the coming year. 

<ul class="summary-bullets"><li>Macdonald said that Uber expects to deploy robotaxis on its Uber app across 10-plus cities by this time next year.</li><li>The Uber COO also noted that Uber’s partners outside of the US, such as Chinese robotaxi players WeRide and Pony AI, are starting to lower their costs.</li></ul> Uber Technologies (UBER) COO Andrew Macdonald believes the hardware cost for autonomous vehicles has to come down before they can be financially viable, though technological advancement in the field is significant.Uber has partnerships in place with multiple robotaxi companies, including Pony AI, WeRide and Alphabet Inc’s Waymo. The company is now looking to scale deployments across multiple cities and geographical regions where these robotaxis will be deployed alongside human drivers.“Writing L4 software that’s fully capable of driving on its own safely — and not just as safe as a human, but 10x as safe as a human — I venture to say that problem is almost largely solved,” Macdonald <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.youtube.com/live/e7ZUU9HoJOw?t=23982s">said</a> at the Web Summit 2025 conference in Lisbon on Tuesday.<h2 class="st-heading-2">Hurdles To Cross</h2>However, despite the technological advancement, there are still real problems with commercialization, such as safety record, supportive regulatory frameworks and questions regarding asset ownership and infrastructure, he noted.“...at the end of the day, these are going to be expensive assets for some time and the return on an expensive asset is always going to be driven by utilization,” he noted. &nbsp;According to Macdonald, in Austin, Texas, the average Waymo robotaxi deployed on Uber is busier than 99% of the drivers in the company. However, challenges regarding costs persist, preventing robotaxis from fully replacing human-driven ride-hailing services.“...challenge is that the underlying hardware is still quite expensive and your operating costs in the form of all the pieces of the deployment structure that I talked about are still significant, so the economics don't work today. I think what you need to see is the hardware cost come down. It probably needs to go somewhere from a half to a quarter of where it is today,” he noted.<h2 class="st-heading-2">Cost Reduction Efforts</h2>Macdonald, however, also noted that Uber’s partners outside of the US, such as Chinese robotaxi players WeRide and Pony AI, are starting to lower their costs.“The Chinese automotive sector has a proven track record of being able to iterate and have great tech but also bring the cost of that tech way down with scale. And so it's gonna happen,” he said.Macdonald said that Uber expects to deploy robotaxis on its Uber app across 10-plus cities by this time next year. Currently, the company has deployed robotaxis on its app across about four cities.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/UBER">UBER stock</a> stayed within the ‘bearish’ territory over the past 24 hours, while message volume fell from ‘normal’ to ‘low’ levels.<figure class="image"><img style="aspect-ratio:621/64;" src="data:image/png;base64,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" width="621" height="64" alt="UBER's Sentiment Meter and Message Volume as of 7:39 a.m. ET on Nov. 12, 2025 | Source: Stocktwits"><figcaption>UBER's Sentiment Meter and Message Volume as of 7:39 a.m. ET on Nov. 12, 2025 | Source: Stocktwits</figcaption></figure>UBER stock is up by 57% this year and by about 32% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/cormedix-stock-soars-pre-market-after-earnings-beat-higher-full-year-guidance/cLPIUcNREdG">Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Andrew Macdonald, President & COO, Uber, and Craig Trudell, Global Automotive Editor, Bloomberg, on Centre stage during day one of Web Summit 2025 at the MEO Arena in Lisbon, Portugal. (Photo By Alex Broadway/Sportsfile for Web Summit via Getty Images)

Uber COO Says Robotaxi Tech Is Largely Ready But Hardware Costs Are Still Too High

Uber has partnerships in place with multiple robotaxi companies, including Pony AI, WeRide and Alphabet Inc’s Waymo.

<ul class="summary-bullets"><li>For the third quarter, the company reported net revenue of $104.3 million, up from the $11.5 million reported in the corresponding quarter of 2024.</li><li>The growth in revenue was driven by higher-than-expected utilization of DefenCath by outpatient dialysis customers, the company said.</li><li>Adjusted earnings before interest, taxes, depreciation and amortization in Q3 came in at $71.9 million, above an expected $40.65 million.</li></ul>&nbsp;Shares of CorMedix Inc. (CRMD) soared 9% in the pre-market session on Wednesday after the company raised its full-year revenue guidance on the heels of upbeat Q3 earnings.The company now <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.globenewswire.com/news-release/2025/11/12/3186117/0/en/CorMedix-Inc-Reports-Third-Quarter-2025-Financial-Results-and-Updates-FY-2025-Guidance.html">expects</a> pro forma net revenue for the full year in a range of $390 million to $410 million, up from its September guidance of $325 to $350 million and higher than a Wall Street estimate of $283.66 million. &nbsp;Fully synergized pro forma adjusted earnings before interest, taxes, depreciation and amortization for 2025 are now expected in a range of $220 – $240 million, higher that the previously estimated $165 million – $185 million.<h2 class="st-heading-2">Q3 Numbers Beat Wall Street Expectations</h2>For the third quarter, the company reported net revenue of $104.3 million, up from the $11.5 million reported in the corresponding quarter of 2024, and above an analyst estimate of $86.02 million.The growth in revenue was driven by higher-than-expected utilization of DefenCath by outpatient dialysis customers, the company said. DefenCath is an FDA-approved catheter lock solution used to reduce catheter-related bloodstream infections in adult patients undergoing chronic hemodialysis through a central venous catheter. It contributed about 85% of the company’s net revenue in the quarter, the company noted.Adjusted earnings before interest, taxes, depreciation and amortization in Q3 came in at $71.9 million, above an expected $40.65&nbsp;&nbsp;&nbsp;&nbsp; million.Diluted earnings per share in the quarter was at $1.26, above an expected $0.63.<h2 class="st-heading-2">Melinta Therapeutics Acquisition</h2>Cormedix completed the acquisition of Melinta for an upfront consideration of $300 million on August 29. The company now expects synergy capture of approximately $30 million, of the total estimated $35 – $45 million, on an annual run-rate basis before the end of 2025.Sales of Melinta’s portfolio of anti-infective products also aided Cormedix’s revenue in the third quarter.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/CRMD">CRMD stock</a> jumped from ‘bearish’ to ‘neutral’ territory over the past 24 hours, while message volume rose from ‘low’ to ‘normal’ levels.CRMD stock is up by 38% this year but down by 4% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/general-motors-races-to-decouple-supply-chain-from-china-report/cLPIHl2RE5r">General Motors Races To Decouple Supply Chain From China: Report</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Cormedix Stock Soars Pre-Market After Earnings Beat, Higher Full-Year Guidance 

The company now expects pro forma net revenue for the full year in a range of $390 million to $410 million, higher than a Wall Street estimate of $283.66 million.  

<ul class="summary-bullets"><li>The deal could reportedly focus on Getir’s delivery business and be valued at as much as $1 billion.</li><li>Bloomberg added that there is no certainty that the talks will lead to a deal.&nbsp;</li><li>The move comes as Uber seeks to expand its delivery business into grocery and retail, away from just food. &nbsp;</li></ul>Uber Technologies Inc. is reportedly in talks with grocery delivery service Getir for a potential deal to expand its delivery operations in Turkey.Bloomberg <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-11-06/uber-said-to-eye-getir-deal-to-expand-in-turkish-delivery-market">reported</a> on Thursday, citing people familiar with the matter, that Uber has been holding preliminary discussions with Getir investor Mubadala Investment about acquiring key parts of the Turkish company.The deal could focus on Getir’s delivery business and be valued at up to $1 billion, the report said. However, the deal value depends on the assets that will ultimately be included in the transaction, the report noted, while also adding that there is no certainty that the talks will lead to a deal.The report also noted that Mubadala is considering selling Getir’s finance business separately. Getir restructured its business last year and closed its overseas operations.<h2 class="st-heading-2">Uber’s Delivery Push</h2>The move comes as Uber seeks to expand its delivery business into grocery and retail, away from just food.Earlier this week, the company reported that its third-quarter revenue increased 20% to $13.5 billion, primarily due to growth in the company’s mobility and delivery businesses. While revenue from the company’s delivery segment rose 29% to $4.5 billion in the quarter, revenue from the mobility segment grew 20% to $7.7 billion, even as freight division revenue remained flat year-on-year.Uber CEO Dara Khosrowshahi said on the company’s earnings call that its ambitions “go well beyond meals.” He added that its grocery and retail business is already approaching a $12 billion Gross Bookings run-rate and is growing significantly faster than food delivery.“As consumers engage more with G&amp;R, they use Uber more broadly and stay with us longer,” he added.<h2 class="st-heading-2">How Did Stocktwits User React?</h2>On Stocktwits, retail sentiment regarding <a href="https://stocktwits.com/symbol/UBER">Uber stock</a> remained in the 'extremely bullish' territory over the past 24 hours, while message volume remained at 'extremely high' levels.UBER stock is up by 52% this year and by about 23% over the past 12 months.Also See:<a href="https://stocktwits.com/news-articles/markets/equity/fdmt-stock-gains-pre-market-after-positive-study-data-for-experimental-drug-in-eye-disease/cL2tFCrREbU"> FDMT Stock Gains Pre-Market After Positive Study Data For Experimental Drug In Eye Disease</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

In this photo illustration, the Uber Technologies Inc logo is seen displayed on a smartphone screen. 

Uber In Talks With Getir To Expand Delivery Services In Turkey: Report

Bloomberg reported on Thursday, citing people familiar with the matter, that Uber has been holding preliminary discussions with Getir investor Mubadala Investment about acquiring key parts of the Turkish company. 

<ul class="summary-bullets"><li>4D-150 demonstrated consistent and durable benefits in patients with wet age-related macular degeneration in the study.&nbsp;</li><li>The company is currently enrolling patients into late-stage trials for the drug.</li><li>Enrollment is continuing ahead of initial projections, CEO David Kirn said. &nbsp;</li></ul>4D Molecular Therapeutics (FDMT) announced on Thursday that its experimental drug 4D-150 demonstrated consistent and durable benefits in patients with wet age-related macular degeneration in an early-to-mid-stage trial.Wet age-related macular degeneration (AMD) is an advanced form of macular degeneration where abnormal blood vessels grow in the retina, leak fluid or blood, and cause a rapid decline in central vision. The proliferation and leakage of abnormal blood vessels is stimulated by vascular endothelial growth factor (VEGF), a protein that promotes the growth of new blood vessels. According to 4D, the disease has a high incidence, with 200,000 individuals estimated to be newly diagnosed every year in the U.S. alone.<h2 class="st-heading-2">Study Findings</h2>4D-150 showed maintenance of visual acuity and control of retinal anatomy in the study, the company <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.4dmoleculartherapeutics.com/news-releases/news-release-details/4dmt-announces-positive-long-term-data-phase-12-prism-clinical">said</a>. The study also reduced treatment burden as patients maintained a consistent and clinically meaningful reduction in supplemental injections in 6-month intervals following dosing with 4D-150 through up to two years of follow-up, it added.4D-150 was further well tolerated with no new safety or intraocular inflammation findings. The drug is aimed at providing multi-year, and potentially lifelong, sustained delivery of anti-VEGF from the retina with a single, safe, intravitreal injection. Anti-VEGF is a treatment that blocks the action of the vascular endothelial growth factor.The company is currently enrolling patients into late-stage trials for the drug. Enrollment is continuing ahead of initial projections, according to CEO David Kirn.“With the robust PRISM dataset and our APAC region strategic partnership with Otsuka announced last week, we are well positioned for global success in our Phase 3 4FRONT clinical trials, which continue to enroll ahead of initial projections,” he added. &nbsp;<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Shares of the company soared 13% in the pre-market session at the time of writing. On Stocktwits, retail sentiment regarding <a href="https://stocktwits.com/symbol/FDMT">FDMT stock</a> remained within the ‘bullish’ territory, while message volume remained at ‘high’ levels over the past 24 hours.FDMT stock is up 89% this year and approximately 26% over the past 12 months.&nbsp;Also See: <a href="https://stocktwits.com/news-articles/markets/equity/dupont-announces-2-billion-share-buyback-stock-tumble-7-today/cL2t8hLREbz">DuPont Announces $2 Billion Share Buyback: Why Did The Stock Tumble 7% Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com

Global stock market chart and trading board - stock photo

FDMT Stock Gains Pre-Market After Positive Study Data For Experimental Drug In Eye Disease

The drug showed maintenance of visual acuity, control of retinal anatomy, and reduction of treatment burden at all time points with up to 2 years of follow-up. 

<ul class="summary-bullets"><li>Biohaven was seeking approval for its drug Vyglxia in the treatment of Spinocerebellar ataxia.&nbsp;</li><li>The company is in the process of formally requesting a meeting as soon as possible to determine the potential next steps.</li><li>Biohaven added that it may pause or delay non-priority programs to maintain its cash runway in the near term.&nbsp; &nbsp;</li></ul>Shares of Biohaven (BHVN) slumped 44% in the premarket session on Wednesday after the U.S. Food and Drug Administration refused to approve its drug Vyglxia in the treatment of Spinocerebellar ataxia (SCA).Spinocerebellar ataxia is a neurodegenerative disorder characterized by progressive loss of voluntary motor control and atrophy of the brain’s cerebellum and brainstem. According to Biohaven, the condition affects approximately 15,000 people in the United States, but there are currently no FDA-approved treatments available.<h2 class="st-heading-2">What Did The FDA Say?</h2>In a <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://ir.biohaven.com/news-releases/news-release-details/fda-issues-complete-response-letter-biohavens-vyglxia">letter</a>, the FDA cited issues including potential bias, design flaws, lack of pre-specification, and unmeasured confounding factors in Biohaven’s drug studies. The agency also recommended that the company meet with the agency to discuss the evidence that will be needed to support a future application.Biohaven is in the process of formally requesting a meeting as soon as possible to determine the potential next steps.<h2 class="st-heading-2">Biohaven’s Response</h2>Biohaven CEO Vlad Coric expressed disappointment over the FDA decision. “There are a number of common sense solutions and regulatory tools that the (FDA’s) Office of Neuroscience could have applied including a fair hearing of the drug's efficacy and safety risks at an Advisory Committee of experts and patients, post-marketing studies, labelling limitations or an accelerated approval pathway,” he said.<h2 class="st-heading-2">Steps Forward</h2>In the meantime, Biohaven said it will prioritize resources to focus all its research and development resources on other key programs in its portfolio.Over the next year, the company will focus on three late-stage, clinical programs with the greatest potential for value generation. It has also initiated strategic portfolio and cost optimization across multiple programs to achieve an approximately 60% reduction in annual direct research and development spend.The company added that it may pause or delay non-priority programs to maintain its cash runway.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/BHVN">BHVN stock</a> stayed within the ‘extremely bullish’ territory over the past 24 hours, while message volume stayed at ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:622/57;" src="data:image/png;base64,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" width="622" height="57" alt="BHVN's Sentiment Meter and Message Volume as of 7:12 a.m. ET on Nov. 5, 2025 | Source: Stocktwits"><figcaption>BHVN's Sentiment Meter and Message Volume as of 7:12 a.m. ET on Nov. 5, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user expressed hopes for the pipeline.<stembedurl>https://stocktwits.com/Dheeraj_6/message/634978290</stembedurl>BHVN stock is down 63% this year and approximately 73% over the past 12 months.&nbsp;Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-upstart-stock-is-plunging-over-14-premarket-today/cL2qgqXREGX">Why Upstart Stock Is Plunging Over 14% Premarket Today</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the Biohaven logo is displayed on the screen of a tablet. (Photo Illustration by Sheldon Cooper/SOPA Images/LightRocket via Getty Images)

BHVN Stock Tumbled A Whopping 44% Today – What Did The FDA Letter Say?

The FDA cited issues including potential bias, design flaws, lack of pre-specification, and unmeasured confounding factors in Biohaven’s Vyglxia studies to refuse drug approval. 

The FDA cited issues, including potential bias, design flaws, lack of pre-specification, and unmeasured confounding factors in Biohaven’s Vyglxia studies to refuse drug approval. 

<ul class="summary-bullets"><li>William Blair downgraded Fiserv to ‘Market Perform’ from ‘Outperform’ and noted that it no longer recommends the stock, given a "shocking" third quarter.</li><li>Wolfe Research downgraded Fiserv to ‘Peer Perform’ from ‘Outperform,’ according to TheFly, on the heels of the guidance cut that it says "raised structural concerns."</li><li>Fiserv announced that Paul Todd has been named the company’s Chief Financial Officer, effective October 31, succeeding Robert Hau.</li></ul>Fiserv Inc. (FI) shares were down nearly 44%,&nbsp;on track for&nbsp;their largest one-day decline on Wednesday, as the company also witnessed multiple Wall Street downgrades following leadership transitions and a cut in annual forecasts.Wolfe Research downgraded Fiserv to ‘Peer Perform’ from ‘Outperform,’ according to TheFly on the heels of the guidance cut that it says "raised structural concerns." The firm noted that it was "tactically cautious" and previewed a potential guidance cut.The firm said that the combination of materially weaker third-quarter results across segments, along with acknowledgement of several short-term and unsustainable levers used at the company in recent years that need to be reversed, led Wolfe Research to see "too much uncertainty in the medium-term through a necessary transition period.”The company stock fell about 44%, hitting its biggest percentage drop ever at $71.22, according to Koyfin. Retail sentiment on Fiserv jumped to ‘extremely bullish’ from ‘bearish’ territory compared to a day ago, with message volumes at ‘extremely high’ levels, according to data from Stocktwits.<h2 class="st-heading-2">William Blair Calls It A “Shocking Q3”</h2>William Blair downgraded Fiserv to ‘Market Perform’ from ‘Outperform,’ according to TheFly. The firm noted that it no longer recommends the stock given a "shocking" third-quarter revenue and earnings per share miss and abrupt management transition.Relatively new CEO Mike Lyons is now in a difficult position to figure out what went wrong, the firm noted, adding that it has "low conviction" in the underpinnings of Fiserv's merchant competitive position.On Wednesday, the company announced that Paul Todd has been named the company’s Chief Financial Officer, effective October 31, succeeding Robert Hau, who will serve as a senior advisor through the first quarter of 2026.<h2 class="st-heading-2">Buying Opportunity In Fiserv Peers</h2>Wells Fargo said that it sees buying opportunities in Fiserv, Global Payments (GPN), Block (XYZ) and Toast (TOST) with the stocks trading down in sympathy with Fiserv.Fiserv's issues are largely company-specific and execution related, which is likely benefitting its peers, Wells Fargo said. As such, the firm said it believes read-throughs from the company's earnings report to peers are "misguided" and still expects FIS, Global Payments, Block and Toast to report solid results.<a href="https://stocktwits.com/symbol/FI">Shares of Fiserv</a> have declined over 65% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/caterpillar-sees-strong-growth-in-energy-segment-fueled-by-ai-infrastructure-demand/cLGZsDmR3wD">Caterpillar Sees Strong Growth In Energy Segment Fueled By AI Infrastructure Demand</a>

In this photo illustration, the Fiserv company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Fiserv Shares Plunge 44% In Record One-Day Drop As Company Gets Wall Street Downgrades On Leadership Changes, Forecast Cuts

Wolfe Research downgraded Fiserv to ‘Peer Perform’ from ‘Outperform,’ according to TheFly, on the heels of the guidance cut that it says "raised structural concerns."

Vanguard Group, Inc. - Vanguard U.S. Momentum Factor ETF

Buying

Holding

Selling or trimming

Watching from the sidelines

What are you doing with Alphabet ($GOOGL) stock as it hits fresh all-time highs?

VFMO
Vanguard Group, Inc. - Vanguard U.S. Momentum Factor ETF

Feed

News

Sentiment

Fundamentals

Info

Latest VFMO News

VFMOVanguard Group, Inc. - Vanguard U.S. Momentum Factor ETF